Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Cognition Therapeutics Inc (CGTX)

74 + Investors. Track Smart Money conviction in CGTX. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -3
Streak
1Q ▼
Buyers last Q
51%

Smart Money Signals — CGTX

Based on 74 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their CGTX positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
🏔️

At the ownership peak (96% of max)

96% of all-time peak
74 hedge funds hold CGTX right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +54% more funds vs a year ago

fund count last 6Q
+26 new funds entered over the past year (+54% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟡

Slight buying edge — 51% buying

30 buying29 selling
Last quarter: 30 funds bought or added vs 29 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
➡️

Steady new buyers — ~12 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 8 → 30 → 17 → 12. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
📌

Mixed — 27% long-term, 42% new

■ 27% conviction (2yr+) ■ 31% medium ■ 42% new
Of the 74 current holders: 20 (27%) held >2 years, 23 held 1–2 years, and 31 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
💎

Buying through price weakness — shares -9%, value -94%

Value
-94%
Shares
-8%
Last quarter: funds added -9% more shares while total portfolio value only changed -94%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
📊

Peak discovery — momentum slowing

12 → 8 → 30 → 17 → 12 new funds/Q
New funds entering each quarter: 8 → 30 → 17 → 12. CGTX is well-known in the hedge fund world, but fresh entries are gradually declining. The explosive phase of institutional discovery is likely behind us.
📊

Mixed cohorts — 32% veterans, 53% new entrants

■ 32% veterans ■ 15% 1-2yr ■ 53% new
Of 74 current holders: 24 (32%) held 2+ years, 11 held 1–2 years, 39 (53%) entered in the past year. Balanced distribution — some institutional memory, some recent momentum buyers.
📋

Smaller funds dominant — 10% AUM from top-100

10% from top-100 AUM funds
15 of 74 holders rank in the top 100 by AUM, but together hold only 10% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
4.6
out of 10
Moderate Exit Risk
Exit risk score 4.6/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — CGTX

In 2026 Q1, 30 hedge funds were net buyers of CGTX (12 opened a new position, 18 added to an existing one), while 29 reduced or exited (14 trimmed, 15 sold completely) — a 51% buyer ratio, indicating a slight buying edge. Net fund flow last quarter: -3 funds (more exits than new entries). Total institutional holders: 74.

Hedge Fund Ownership: CGTX

How many hedge funds hold CGTX — quarterly history vs. share price
Quarterly hedge fund ownership of CGTX vs. share price

Market Analysis: CGTX

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: CGTX

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Cognition Therapeutics Inc (CGTX) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much CGTX has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 81d ago
CGTX
+90.9%
XLV
+2.1%

CGTX outperformed XLV by +88.8% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 36d ago
CGTX
+27.2%
XLV
+3.2%

Since the filing became public, CGTX outperformed XLV by +24.0% .

Interpretation: The stock has meaningfully outrun its sector. The trade has partially played out; entry is at a premium to the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

7 top-rated funds 1 high-conviction
Consensus
3.9
/ 10
breadth
×
Elite
0.9
/ 10
conviction
Hedge Fund Positioning: CGTX
74 + Investors

Track Smart Money conviction in CGTX. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 74 77 -3.9%
13F Shares 21M 23M -8.84%
Total Value $16M $290M -94.41%
New Positions 12 17 -5
Increased Positions 18 17 +1
Closed Positions 15 8 +7
Reduced Positions 14 16 -2
Total Calls 0 0 -
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: CGTX

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

74 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in CGTX. Verified SEC 13F-HR filings.

QUARTER:
Top 25 CGTX holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 BIOS Capital Management, LP 8.63% 6,000,000 $4.6M
2 CM Management, LLC 0.25% 400,000 $304K
3 Dauntless Investment Group, LLC 0.22% 431,000 $327K
4 Chescapmanager LLC 0.07% 997,029 $757K
5 American Financial Group Inc 0.06% 205,000 $156K
6 Hilton Capital Management, LLC 0.03% 548,950 $417K
7 DAVENPORT & Co LLC 0.01% 2,892,808 $2.2M
8 Fca Corp /Tx 0.01% 52,536 $40K
9 Voss Capital, LP 0.01% 200,000 $152K
10 Sigma Planning Corp 0.01% 337,765 $257K
11 Catalyst Funds Management Pty Ltd 0.01% 52,800 $40K
12 Texas Capital Bank Wealth Management Services Inc 0.01% 123,296 $94K
13 Two Sigma Securities, LLC 0.00% 31,863 $24K
14 XTX Topco Ltd 0.00% 195,803 $149K
15 McAdam, LLC 0.00% 69,953 $53K
16 Tocqueville Asset Management L.P. 0.00% 195,000 $148K
17 Bangor Savings Bank 0.00% 34,019 $26K
18 Essex Financial Services, Inc. 0.00% 40,000 $30K
19 Barry Investment Advisors, LLC 0.00% 10,000 $8K
20 Renaissance Technologies LLC 0.00% 1,117,136 $848K
21 Bryn Mawr Trust Advisors, LLC 0.00% 29,050 $22K
22 CWA Asset Management Group, LLC 0.00% 25,250 $19K
23 Empirical Financial Services, LLC d.b.a. Empirical Wealth Management 0.00% 48,000 $36K
24 Circle Wealth Management, LLC 0.00% 48,842 $37K
25 Private Management Group Inc 0.00% 24,000 $18K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Cognition Therapeutics Inc (CGTX)

What does the Smart Money Trend signal show for CGTX?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their CGTX positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for CGTX?

Slight buying edge — 51% buying: Last quarter: 30 funds bought or added vs 29 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for CGTX holders?

Smaller funds dominant — 10% AUM from top-100: 15 of 74 holders rank in the top 100 by AUM, but together hold only 10% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held CGTX?

Mixed — 27% long-term, 42% new: Of the 74 current holders: 20 (27%) held >2 years, 23 held 1–2 years, and 31 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy Cognition Therapeutics Inc (CGTX) following the 2026 Q1 hedge fund 13F filings?

As of today, CGTX has moved +27.2% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.2% for the XLV sector ETF — an outperformance of +24.0%. Since the quarter end (March 31, 2026), CGTX has gained +90.9% vs +2.1% for XLV. The stock has meaningfully outrun its sector. The trade has partially played out; entry is at a premium to the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →